The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:2151 May 22, 2003 Number 21
NextNext

Signaling Molecules in Pulmonary Hypertension

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Du, L.
-PubMed Citation
To the Editor: In their thought-provoking article, Du et al. (Feb. 6 issue)1 report a striking correlation between the level of angiopoietin-1 in the lung and the degree of pulmonary vascular resistance in patients with pulmonary hypertension. The fact that these patients had various types of disease makes these findings difficult to interpret, especially since the majority of patients had chronic thromboembolic pulmonary hypertension and underwent thromboendarterectomy.

In contrast to other types of pulmonary hypertension, increased pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension is due mostly to the obliteration of proximal vessels. In fact, the absence of major involvement . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.